Ubrolexin Boehringer Ingelheim
Ubrolexin Boehringer Ingelheim – product information
Ubrolexin® intramammary suspension for lactating dairy cows
Each tube contains:
Cefalexin (as monohydrate): 200 mg
Kanamycin (as monosulphate): 100,000 I.U.
Indications
Treatment of clinical mastitis in lactating dairy cows for bacteria susceptible to the combination of cefalexin and kanamycin such as Staphylococcus aureus, Streptococcus dysgalactiae, Streptococcus uberis and Escherichia coli.
Dosage & Administration
Treat the infected quarter(s) twice, leaving an interval of 24 hours between treatments.